Skip to main content
. 2010 Sep 10;29(4):581–594. doi: 10.1007/s10555-010-9248-x

Fig. 3.

Fig. 3

Absolute reduction in overall recurrences and distant metastases in the a Arimidex, Tamoxifen Alone, or Combination trial (hormone receptor-positive patients) at 2.5 years [3] and b Breast International Group 1-98 at 2 years [6]. ANA anastrozole; LET letrozole; TAM tamoxifen